Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H13N5O |
| Molecular Weight | 219.2431 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C\C(CO)=C/CNC1=NC=NC2=C1N=CN2
InChI
InChIKey=UZKQTCBAMSWPJD-FARCUNLSSA-N
InChI=1S/C10H13N5O/c1-7(4-16)2-3-11-9-8-10(13-5-12-8)15-6-14-9/h2,5-6,16H,3-4H2,1H3,(H2,11,12,13,14,15)/b7-2+
| Molecular Formula | C10H13N5O |
| Molecular Weight | 219.2431 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
Sample Use Guides
Zeatin has gerontomodulatory, youth preserving and anti-aging effects on serially passaged human adult skin fibroblasts undergoing aging in vitro. There were no immediate negative or toxic effects in terms of cell attachment, cell proliferation, cell survival, cytoskeletal organization, and cellular growth by treatment with zeatin concentrations between 1 and 200 microM. During long-term treatment, cells could be maintained throughout their replicative lifespan in the presence of 40, 80, and 200 microM zeatin, but the optimal concentration of zeatin's anti-aging and youth-preserving effects was found to be 80 microM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:01:55 GMT 2023
by
admin
on
Fri Dec 15 19:01:55 GMT 2023
|
| Record UNII |
7I6OOJ9GR6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ZEATIN
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | |||
|
DB11337
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | |||
|
7I6OOJ9GR6
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | |||
|
m11585
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | Merck Index | ||
|
449093
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | |||
|
7I6OOJ9GR6
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | |||
|
15333
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | |||
|
1440227
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID9040631
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | |||
|
7689
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | |||
|
16522
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | |||
|
1637-39-4
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY | |||
|
zeatin
Created by
admin on Fri Dec 15 19:01:55 GMT 2023 , Edited by admin on Fri Dec 15 19:01:55 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
